ChipDX was an online data analysis platform I developed in 2010 to analyse genomic data from cancer patients and generate accurate, clinically-useful results.

After uploading a patient’s raw data file, the user could select from one or more analysis modules, including data quality control, prediction of tumour recurrence/survival, treatment response or identification of a metastatic tumour’s primary tissue of origin.

chipdx_screencap was developed using Microsoft .NET, SQL Server, R, Bioconductor and various Affymetrix components. More information can be found in this flyer (5MB PDF)

The system can be accessed for research-use-only at and is now owned by Signal Genetics, where it is used to manage the analysis and reporting of a proprietary genetic test for patients diagnosed with multiple myeloma; MyPRS.